Do you want to take scientific ownership of bioanalytical and biomarker strategies across preclinical and clinical development programs? Are you motivated by translating complex PK, immunogenicity and biomarker data into decisions that help advance new drug candidates? Then this role could be an exciting next step in your career.
Drive bioanalytical strategy across our development portfolio
As an experienced Scientist in Bioanalytical Sciences, you will serve as the bioanalytical and biomarker lead across selected preclinical and clinical development programs. You will be responsible for strategies, methods, workstreams and execution within drug quantitation, anti-drug antibodies (ADA), immunogenicity and biomarkers.
You will work closely with colleagues across toxicology, DMPK, preclinical pharmacology, clinical pharmacology and clinical operations to ensure high-quality data generation, regulatory alignment and seamless integration into development decision-making.
Your primary responsibilities
In this role, you will be a central scientific expert and operational driver of bioanalytical activities.
Your main responsibilities will include:
- Owning and driving integrated PK/drug quantitation, ADA and biomarker strategies across preclinical and clinical programs.
- Developing fit-for-purpose bioanalytical approaches, including ligand-binding assays, LC-MS/MS, cell-based assays, and receptor occupancy methodologies.
- Leading method development, qualification, validation, and lifecycle management in collaboration with external bioanalytical laboratories.
- Ensuring high-quality sample analysis, data interpretation, and reporting to support program decisions and regulatory submissions.
- Providing expert input into nonclinical and clinical protocols, including schedules of assessment, sample handling, and bioanalytical feasibility.
- Partnering with clinical pharmacology, clinical operations, toxicology, and DMPK to align bioanalytical objectives and deliverables with program goals.
- Managing CRO and vendor selection, qualification, and oversight across bioanalytical laboratories, specialty assay providers, and central laboratories.
- Acting as the bioanalytical subject matter expert on project teams and supporting due diligence assessments and the integration of data into PK/PD modelling, dose selection, and translational strategies.
Experienced bioanalytical scientist with strong translational mindset
We imagine that you bring solid experience from bioanalytical sciences within drug development and that you are comfortable working across both preclinical and clinical development. You combine scientific depth with the ability to collaborate, influence and deliver through external partners and cross-functional teams.
To succeed in this role, you will likely have:
- PhD, MSc, or equivalent degree in life sciences, pharmacology, immunology, bioanalytical sciences, biochemistry, or related disciplines.
- 8+ years of relevant experience in regulated quantitative bioanalysis, biomarkers, and drug development, and/or commensurate experience at a CRO, preferably with deep multimodal bioanalytical proficiency, with level and title determined based on experience and demonstrated expertise.
- Experience with PK bioanalysis, ADA/immunogenicity, and biomarker strategies in preclinical and/or clinical development.
- Hands-on understanding of relevant assay platforms such as ligand-binding assays, LC-MS/MS, cell-based assays, and receptor occupancy methods.
- Experience with method development, qualification, validation, and outsourced bioanalytical workstreams.
- Knowledge of GLP/GCLP and regulatory expectations for bioanalytical data supporting development programs.
- The ability to translate scientific strategy into practical sampling plans, operational execution, and decision-ready data.
- Strong collaboration and communication skills, with the confidence to act as a trusted subject matter expert bridging development functions.
A role with broad impact and development potential
You will join a collaborative and ambitious development environment where your expertise will help shape how PK, ADA, and biomarker strategies are defined, integrated and applied across the portfolio. The role offers the opportunity to combine operational ownership with increasing strategic influence as our development activities grow.
You will play an important role in building scalable, consistent, and high-quality processes for outsourced bioanalysis and biomarker workflows. Over time, you will contribute to key development decisions, including study design, dose selection, biomarker frameworks, and external diligence activities.
Some travel should be expected, primarily to interact with vendors, collaborators and CROs, and to attend selected key conferences. The role is available to support an immediate business need.
Application and deadline
Please apply no later than August 2, 2026 by uploading your motivated cover letter, resumé, and relevant diplomas on our website.
For questions about the position, please contact VP, Non-Clinical Development, Eric Gaukel (ega@gubra.dk).
We are looking forward to receiving your application.
About Gubra
Gubra is a disease-agnostic techbio company specialized in peptide-based drug discovery and development as well as preclinical contract research services striving for excellence at all levels. We insist on doing things efficiently – and often differently - to reach the results we aim for. Our vision is to become leaders in the path towards a more sustainable and healthier world. We do that by facilitating the discovery of new medicine, and by acting and inspiring others to fight the ongoing climate and biodiversity crises.
Gubra’s activities are focused on the early stages of drug development and are organised in two main highly synergistic business areas: Biotech and CRO Services. We generate our revenue by performing research for life science companies as well as by partnering projects from our discovery and development pipeline.
Our therapeutic focus is within metabolic and fibrotic diseases, and we specialize in in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. In addition, we offer a full palette of advanced transcriptomics. Our ML/AI-driven peptide drug discovery platform streaMLine enables us to rapidly develop a peptide hit into a non-clinical candidate ready for development. Through a constant focus on high quality, scientific excellence, speed, and solid teamwork we have established ourselves as a highly professional and competent partner in the market.
People are our greatest asset, and our team consists of around 300 employees of which many are located in Hørsholm, Denmark. The mix of people from different cultures and educational backgrounds combined with our entrepreneurial mindset have greatly impacted our working environment, which is characterized by entrepreneurial drive, scientific curiosity, and teamwork – we join forces!
